7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.

      The Journal of Immunology Author Choice
      Amino Acid Sequence, Animals, Antibodies, Monoclonal, administration & dosage, Antibody Formation, genetics, Cytotoxicity, Immunologic, drug effects, Epitopes, B-Lymphocyte, immunology, Epitopes, T-Lymphocyte, Female, Granulocyte-Macrophage Colony-Stimulating Factor, Hemagglutinin Glycoproteins, Influenza Virus, Humans, Immunologic Memory, Influenza A virus, Injections, Intramuscular, Lymphocyte Activation, Lymphocyte Depletion, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Molecular Sequence Data, Neoplasm Transplantation, Plasmids, chemical synthesis, T-Lymphocytes, Cytotoxic, T-Lymphocytes, Helper-Inducer, Thymoma, Vaccination, methods, Vaccines, DNA, Vaccines, Synthetic, Vaccinia virus

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Development of CD8 alphabeta CTL epitope-based vaccines requires an effective strategy capable of co-delivering large numbers of CTL epitopes. Here we describe a DNA plasmid encoding a polyepitope or "polytope" protein, which contained multiple contiguous minimal murine CTL epitopes. Mice vaccinated with this plasmid made MHC-restricted CTL responses to each of the epitopes, and protective CTL were demonstrated in recombinant vaccinia virus, influenza virus, and tumor challenge models. CTL responses generated by polytope DNA plasmid vaccination lasted for 1 yr, could be enhanced by co-delivering a gene for granulocyte-macrophage CSF, and appeared to be induced in the absence of CD4 T cell-mediated help. The ability to deliver large numbers of CTL epitopes using relatively small polytope constructs and DNA vaccination technology should find application in the design of human epitope-based CTL vaccines, in particular in vaccines against EBV, HIV, and certain cancers.

          Related collections

          Author and article information

          Comments

          Comment on this article